Your browser doesn't support javascript.
loading
A systematic literature review of the economic and healthcare resource burden of cytomegalovirus.
Diaz-Decaro, John; Myers, Evan; Mucha, Jacek; Neumann, Monika; Lewandowski, Witold; Kaczanowska, Magdalena; Schmidt, Elvira; Natenshon, Andrew; Talarico, Carla; Buck, Philip O.
Affiliation
  • Diaz-Decaro J; Moderna, Inc., Cambridge, MA, USA.
  • Myers E; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
  • Mucha J; Certara, Inc., Krakow, Poland.
  • Neumann M; Certara, Inc., Lörrach, Germany.
  • Lewandowski W; Certara, Inc., Krakow, Poland.
  • Kaczanowska M; Certara, Inc., Krakow, Poland.
  • Schmidt E; Certara, Inc., Lörrach, Germany.
  • Natenshon A; Moderna, Inc., Cambridge, MA, USA.
  • Talarico C; Moderna, Inc., Cambridge, MA, USA.
  • Buck PO; Moderna, Inc., Cambridge, MA, USA.
Curr Med Res Opin ; 39(7): 973-986, 2023 07.
Article in En | MEDLINE | ID: mdl-37395088
ABSTRACT

OBJECTIVE:

Cytomegalovirus (CMV) can infect individuals at any age, including infants, who may contract it from infected mothers (congenital CMV [cCMV]). Whereas CMV infection is typically asymptomatic or causes mild illness in healthy individuals, infection can result in severe outcomes in immunocompromised individuals and in infants with cCMV. This systematic review aims to characterize the economic impact of CMV and cCMV infections.

METHODS:

Medline, Embase, and LILACS databases were searched for publications reporting the economic impact of cCMV and CMV infections across all age groups. Manuscripts published between 2010 and 2020 from Australia, Latin America, Canada, Europe, Israel, Japan, the United States, and global (international, worldwide) studies were included; congress materials were excluded. Outcomes of interest included cCMV- and CMV-attributable direct costs/charges, resource utilization, and indirect/societal costs.

RESULTS:

Of 751 records identified, 518 were excluded based on duplication, population, outcome, study design, or country. Overall, 55 articles were eligible for full-text review; 25 were further excluded due to population, outcome, study design, or congress abstract. Two publications were additionally identified, resulting in economic impact data compiled from 32 publications. Of these, 24 publications reported cost studies of cCMV or CMV, including evaluation of direct costs/charges, healthcare resource utilization, and indirect/societal costs, and 7 publications reported economic evaluations of interventions. The populations, methods and outcomes used across these studies varied widely.

CONCLUSIONS:

CMV and cCMV infections impose a considerable economic impact on different countries, populations, and outcomes. There are substantial evidence gaps where further research is warranted.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytomegalovirus Infections / Cytomegalovirus Type of study: Health_economic_evaluation / Systematic_reviews Limits: Female / Humans / Infant Language: En Journal: Curr Med Res Opin Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytomegalovirus Infections / Cytomegalovirus Type of study: Health_economic_evaluation / Systematic_reviews Limits: Female / Humans / Infant Language: En Journal: Curr Med Res Opin Year: 2023 Document type: Article Affiliation country: United States